Financial, market and economic news

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – BMRN

NEW YORK, Oct. 17, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioMarin Pharmaceuticals, Inc. (“BioMarin” or the “Company”) (NASDAQ: BMRN) and certain of its officers. The class action, filed in United States District Court for the…

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy